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Abstract  13 
Autophagy is a conserved intracellular degradation pathway essential for protein 14 
homeostasis, survival and development. Defects in autophagic pathways have been 15 
connected to a variety of human diseases including cancer and neurodegeneration. In 16 
the process of macroautophagy, cytoplasmic cargo is enclosed in a double-membrane 17 
structure and fused to the lysosome to allow for digestion and recycling of material. 18 
Autophagosome formation is primed by the ULK complex, which enables the 19 
downstream production of PI(3)P, a key lipid signalling molecule, on the phagophore 20 
membrane. The PI(3)P is generated by the PI3 kinase (PI3K) complex, consisting of 21 
the core components VPS34, VPS15 and Beclin 1. Beclin 1 is a central player in 22 
autophagy and constitutes a molecular platform for the regulation of autophagosome 23 
formation and maturation. Post-translational modifications of Beclin 1 affect its stability, 24 
interactions and ability to regulate PI3K activity, providing the cell with a plethora of 25 
strategies to fine-tune the levels of autophagy. Being such an important regulator, 26 
Beclin 1 is a potential target for therapeutic intervention and interfering with the post-27 
translational regulation of Beclin 1 could be one way of manipulating the levels of 28 
autophagy. In this review, we provide an overview of the known post-translational 29 
modifications of Beclin 1 that govern its role in autophagy, and how these modifications 30 
are maintained by input from several upstream signalling pathways. 31 
 32 
Facts 33 
 2 
 Beclin 1 is a core component of the PI3K complex, important for producing 34 
PI(3)P on the phagophore membrane in order to recruit downstream 35 
autophagy effectors. 36 
 Beclin 1 is a multi-domain protein, with a large interactome that facilitates 37 
regulation of autophagy in both a positive and negative manner. 38 
 Post-translational modifications of Beclin 1 affect protein stability, 39 
confirmation, activity and its interactome, and can be used as a molecular 40 
rheostat to fine-tune autophagic activity. 41 
 Targeting Beclin 1 modifiers to regulate Beclin 1 post-translational 42 
modifications could provide a possible therapeutic intervention for 43 
upregulating autophagy. 44 
 45 
 46 
Open Questions 47 
 48 
 Understand the full repertoire of Beclin 1 post-translational modifications 49 
relevant to autophagy 50 
 Understand the relevance of Beclin 1 post-translational modifications to the 51 
activities of the different Beclin 1 complexes  52 
 Can regulation of Beclin 1 post-translational modifications be exploited as a 53 
therapeutic strategy to counteract accumulation of aggregate-prone proteins 54 
in neurodegenerative diseases? 55 
 56 
 57 
Introduction 58 
Autophagy is an essential and widely conserved cellular degradation process that 59 
plays a crucial role in housekeeping and stress survival. In the process of 60 
macroautophagy (henceforth referred to as autophagy), a portion of cytoplasmic 61 
content, including proteins and organelles, is sequestered into a double-membrane 62 
structure called the phagophore. The phagophore membrane expands to fully enclose 63 
its cargo, forming the autophagosome, and the autophagosome is trafficked along 64 
microtubules to ultimately fuse with the lysosome1, 2. Fusion with this lytic compartment 65 
ensures the enzymatic degradation of the cargo and subsequent release of recycled 66 
material. Autophagy was initially believed to be a non-selective bulk degradation 67 
process, but recent data indicate that it is often selective using specific receptors for 68 
cargo recognition3. Autophagy has been shown to aid in clearing intracellular 69 
aggregate-prone proteins underlying neurodegenerative diseases, including 70 
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Alzheimer and Parkinson disease, and upregulating autophagy induction may be a 71 
promising therapeutic approach for these types of diseases4. 72 
 73 
PI(3)P production on the phagophore membrane  74 
Under normal conditions, cells maintain basal levels of autophagy to maintain 75 
homeostasis. In addition, autophagy can be triggered by a variety of stimuli such as 76 
nutrient deprivation, metabolic imbalance, protein aggregation and oxidative stress. 77 
The process of autophagosome biogenesis consists of three main stages: initiation, 78 
nucleation and expansion of the isolation membrane (Figure 1). Key initiating events 79 
in autophagosome biogenesis are dictated by the Unc-51-like autophagy-activating 80 
kinase (ULK) complex, which consists of ULK1 (or ULK2), ATG13, ATG101 and 81 
FIP2005. The ULK complex facilitates the production of phosphatidylinositol-3-82 
phosphate (PI(3)P) by recruiting and activating the kinase VPS34, which is found in 83 
the class III PI3 Kinase (PI3K) complex together with a number of proteins, including 84 
VPS15, ATG14L and Beclin 1, the mammalian ortholog of yeast Atg66 (Figure 1). The 85 
pool of PI(3)P produced at the site of the phagophore, creates a platform for the 86 
recruitment of subsequent autophagy machinery effectors, like WIPI family proteins 87 
and ATG16L. These effectors facilitate conjugation of ATG8 proteins, such as LC3, to 88 
the phagophore membrane, which in turn mediates cargo recruitment, and membrane 89 
extension of the phagophore1, 7, 8.  90 
 91 
The main signalling cues for autophagy initiation converge on PI3K regulation  92 
The early initiation steps of autophagy are regulated by diverse signal-sensing proteins, 93 
including four protein kinases: mammalian target of rapamycin complex 1 (mTORC1), 94 
ULK1, AMP-activated protein kinase (AMPK), and AKT (Figure 2).  Nutrient starvation 95 
is one of the most studied autophagy inducers and the serine/threonine mTOR kinase 96 
plays a major role in sensing nutrient availability9, 10, 11. Lack of nutrients, mainly amino 97 
acids, triggers an intracellular signalling cascade, which inhibits mTORC1 activity12. 98 
Upon starvation, inactivated mTORC1 dissociates from ULK1, resulting in 99 
dephosphorylation and activation of the ULK1 complex13, 14. Activated ULK1 100 
phosphorylates several proteins involved in autophagy initiation and progression, 101 
including the ULK complex components ATG13, ATG101 and FIP20015, and 102 
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downstream effectors like the VPS34, ATG14L, Beclin 1, and AMBRA1 components 103 
of the PI3K complex16, 17, 18.  104 
Autophagy can also be triggered by low energy-conditions through activation of AMPK. 105 
AMPK responds to low energy conditions, detected as changes in the ATP-to-ADP or 106 
ATP-to-AMP ratios, by inhibiting ATP-consuming anabolic processes and by 107 
promoting catabolic processes to restore the proper metabolic balance19. Activated 108 
AMPK triggers autophagy by coordinated activation of ULK1 and negative regulation 109 
of the mTOR kinase20, 21, 22. As described in the following sections, AMPK also exerts 110 
a direct role in regulating components of the PI3K complex. 111 
Another important input for nutrient status is the presence of extracellular growth 112 
factors. The serine threonine kinase AKT (also called Protein kinase B, PKB) is 113 
recruited to active growth factor receptors at the plasma membrane, and binding 114 
initiates its downstream signalling cascade23. AKT phosphorylation activates mTORC1 115 
and inhibits autophagy, and AKT also suppresses autophagy via mTOR-independent 116 
pathways by direct phosphorylation of key autophagy proteins, including components 117 
of the PI3K complex24, 25, 26. 118 
Beclin 1 is a key regulator of autophagy 119 
Beclin 1 was one of the first mammalian autophagy proteins identified27, and BECN1 120 
is an essential gene required for embryonic survival and development28. BECN1 also 121 
functions as a tumour suppressor gene and has been found to be monoallelically 122 
deleted in many cancer types, and Beclin 1 deficiency is also associated with several 123 
neurodegenerative diseases6, 28, 29, 30, 31, 32. Beclin 1 regulates both autophagosome 124 
synthesis and autophagosome maturation, by forming three distinct PI3K complexes 125 
together with the core lipid kinase VPS34 and the regulatory component VPS1533, 34, 126 
35. Complex I includes the core proteins together with ATG14L and is involved in 127 
autophagy initiation and autophagosome formation, whereas in complex II ATG14L is 128 
replaced by UVRAG and this complex regulates autophagosome maturation and 129 
endocytosis33, 36. In the third PI3K complex, RUBICON interacts with Beclin 1, VPS34 130 
and UVRAG of complex II to inhibit lipid kinase activity and reduce autophagic flux34, 131 
35, 37. 132 
 133 
Beclin 1 interacts with the PI3K core component VPS34 and lipid membranes via its 134 
C-terminal ß/α-repeated, autophagy related (BARA) domain (previously denoted 135 
evolutionary conserved domain)38, 39, 40 (Figure 3A-B), and binds ATG14L or UVRAG 136 
in a mutually exclusive manner via its coiled-coiled domain (CCD)36. Additionally, 137 
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Beclin 1 has an unstructured N-terminal domain, followed by a BCL2-homology-3 138 
(BH3) domain and a flexible helical domain (HD) (Figure 3A-B)41, 42. The many domains 139 
of Beclin 1 mediate communications with multiple interaction partners that can alter its 140 
conformation and binding accessibility, thus making Beclin 1 an important molecular 141 
platform for the regulation of PI3K activity and autophagy43. For example, the BH3 142 
domain of Beclin 1 mediates its interaction with the anti-apoptotic protein BCL2 and 143 
this interaction causes a steric block inhibiting PI3K complex formation27, 44. Thus, 144 
BCL2 binding to Beclin 1 inhibits autophagy, and nutrient-dependent regulation of this 145 
interaction modifies the pool of Beclin 1 molecules available for VPS34 interaction44, 45. 146 
Another example of how the Beclin 1 interactome can be utilized as a way of fine-147 
tuning autophagic activity is demonstrated by the interaction with AMBRA1. AMBRA1 148 
is a positive regulator of autophagy and competes with BCL2 for binding to the Beclin 149 
1 BH3 domain46. Binding of AMBRA1 promotes Beclin 1 interaction with VPS34, and 150 
regulates the positioning of the PI3K complex to the site of phagophore formation, 151 
thereby mediating autophagy initiation47, 48. Consequently, modifications that alter the 152 
interaction between Beclin 1 and the PI3K components, or the interaction with 153 
AMBRA1 and BCL2, allow cells to modulate autophagic activity in response to a 154 
multitude of internal and external cues and could also provide potential targets for 155 
pharmaceutical interventions. 156 
 157 
The functions of many proteins directly involved in autophagosome biogenesis are 158 
regulated by their post-translational modifications. These modifications include 159 
phosphorylation, ubiquitination, acetylation, lipidation and redox regulation. The 160 
initiation of autophagy relies on the coordinated spatio-temporal regulation of the levels 161 
of modification of key players constituting the core machinery. In this review, we 162 
provide an overview of the known post-translation modifications of Beclin 1 that govern 163 
its role in autophagy, and how these modifications are maintained by inputs from 164 
upstream signalling pathways. The modifications of Beclin 1 mentioned in this paper 165 
are listed in table 1 together with information on supporting experimental evidence, 166 
and the physiological relevance in terms of effect on autophagy. Post-translational 167 
modifications of other autophagy-related proteins are reviewed elsewhere49.  168 
 169 
Activational phosphorylation of Beclin 1 170 
Phosphorylation is the most intensively studied post-translational modification in the 171 
autophagy process, where a phosphate group is reversibly attached onto serine, 172 
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threonine, or tyrosine residues in the substrate protein50. This post-translational 173 
modification changes protein conformation and can affect accessibility for interactions 174 
and enzymatic activity, and many of the events in autophagy initiation rely on kinase 175 
signalling. Upon amino acid depletion, mTORC1 is inactivated and its inhibitory effect 176 
on the ULK1 complex is relieved13. ULK1 then phosphorylates Beclin 1 on Ser15 177 
(Ser14 in mouse) to induce the activity of ATG14L-containing VPS34 complexes and 178 
stimulate autophagy initiation18. This phosphorylation site is in the N-terminal domain 179 
of Beclin 1 (Figure 3A, 3C; Table 1), which is dispensable for interaction with the PI3K 180 
components. Indeed, mutating the ULK1 phosphorylation site did not affect the Beclin 181 
1 interactions with PI3K components, indicating that this phosphorylation site is 182 
important for the regulatory role of Beclin 1 on VPS34 kinase activity, rather than 183 
affecting complex assembly18, 51. 184 
The activating phosphorylation of Ser15 of Beclin 1 in autophagy initiation is dependent 185 
on ATG14L, which acts as an adaptor for recruiting ULK1 to Beclin 1 at the phagophore 186 
by binding Beclin 1 and ATG13 of the ULK1 complex17. Indeed, expression of a mutant 187 
ATG14L (BATS) that binds Beclin 1 but is unable to localize to the phagophore 188 
severely compromised ULK1-mediated phosphorylation of Beclin 118, 52. In addition, 189 
the recruitment of Beclin 1 to the phagophore is dependent on ULK1-mediated 190 
phosphorylation of AMBRA148. Thus, ULK1-dependent phosphorylation activates 191 
autophagy via two steps: Beclin 1 recruitment and activation. ULK1-dependent 192 
phosphorylation of Beclin 1 Ser15 is also thought to be important during later steps of 193 
autophagosome formation, where UVRAG has been suggested to play a role similar 194 
to ATG14L in stimulating ULK1 activity18. 195 
The activity of ULK1 is also governed by AMPK, another major nutrient-sensing kinase. 196 
During glucose depletion and in low energy states, AMPK phosphorylates ULK1 and 197 
stimulates ULK1-dependent autophagy initiation (Figure 2)21. AMPK also directly 198 
phosphorylates Beclin 1 on Ser90 and Ser93 (Ser91 and Ser94 in mouse) (Table 1)53. 199 
Similar to the activating phosphorylation by ULK1, phosphorylation at these sites do not 200 
alter PI3K complex formation or membrane association, but rather regulate PI3K kinase 201 
activity39, 54.. Interestingly, AMPK exerts a dual regulation of the PI3K activity governed 202 
by ATG14L, where AMPK mediates an inhibitory phosphorylation on VPS34 unless 203 
ATG14L is present to inhibit this phosphorylation and instead stimulates the activational 204 
phosphorylation of Beclin 153. In vitro studies show that UVRAG might play a similar role 205 
in directing AMPK activity to the PI3K complex II, but further investigations of this are 206 
required53. Remarkably, the regulation of AMPK activity by ATG14L seems independent 207 
of phagophore localization of ATG14L, as phosphorylation was still stimulated by an 208 
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ATG14L BATS mutant34, 53. Consequently, the timing and location of AMPK-mediated 209 
phosphorylation of Beclin 1 in respect to autophagy initiation remains unclear. Another 210 
study confirmed that AMPK phosphorylates Beclin 1, but identified Thr388 as the target 211 
residue55. As opposed to to Ser90 phosphorylation, this modification affected PI3K 212 
complex formation by shifting Beclin 1 affinity, disrupting the Beclin 1-BCL2 interaction 213 
and favouring the Beclin 1-VPS34 interaction55. While the importance of AMPK 214 
phosphorylation for inducing autophagy during glucose-deprivation was evident in the 215 
two separate studies, it is not known if and how phosphorylation at the two different sites 216 
are co-regulated. In addition, an autophagy-independent role for Beclin 1 217 
phosphorylation by AMPK has been shown, where phosphorylation of Ser90, Ser93 and 218 
Ser96 enables Beclin 1 to interact with SLC7A11 and initiate ferroptosis, a type of 219 
programmed cell death56. 220 
 221 
Phosphorylation at Ser90 seems to be a key event for Beclin 1 activation and is 222 
considered to be the initial event that mediates further phosphorylation at Ser9339. 223 
Monophosphorylation at S90 is considered sufficient to have an activating effect upon 224 
autophagy induction, and this modification appears to be mediated by different kinases, 225 
depending on cellular context and tissue-type (Figure 3; Table 1). In addition to AMPK-226 
mediated phosphorylation upon glucose starvation, Ser90 is phosphorylated by the 227 
stress-responsive kinases MAPKAPK2/3 upon amino acid starvation, and by Death-228 
associated protein kinase 3 (DAPK3) during serum starvation in mouse skeletal muscle 229 
tissue54, 57. Upon insulin addition, the same site is dephosphorylated by the protein 230 
phosphatase 2A (PP2A). When autophagy is induced by treatment with ionomycin, the 231 
calcium/calmodulin dependent protein kinase II (CaMKII) phosphorylates Beclin 1 at 232 
Ser90 in a manner that increases interaction with VPS34 and activates Beclin 1 via 233 
TRAF6-mediated K63-linked ubiquitination58, 59. Furthermore, the Ser90 234 
phosphorylation site is located within the BCL2-binding domain of Beclin 1, where 235 
phosphorylation and BCL2 binding occurs in a competitive manner, providing another 236 
important point of regulation54, 58. The importance of the Ser90 phosphorylation site is 237 
further emphasized by studies showing that this site is important for the tumour 238 
suppression function of Beclin 154.   239 
 240 
PI3K activity can also be enhanced by phosphorylation of Beclin 1 Ser30, and this 241 
seems to be the preferred mechanism for autophagy activation upon glutamine 242 
deprivation and hypoxia in cancer cell lines, where Ser15/Ser90/Ser96 243 
phosphorylation by ULK1 and AMPK seem less essential60. This phosphorylation is 244 
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accomplished by phosphoglycerate kinase 1 (PGK1) and contributes to cancer cell 245 
proliferation during hypoxic conditions. 246 
 247 
Phosphorylation of Beclin 1 is not only a way to positively regulate autophagy, it can 248 
also be used to reduce PI3K activity and decelerate autophagic flux. In the presence 249 
of extracellular growth factors, AKT phosphorylates Beclin 1 Ser295 and Ser23426. 250 
This phosphorylation bridges Beclin 1 and 14-3-3 proteins and sequesters the protein 251 
complex to intermediate filaments, inhibiting the activation of Beclin 1 in nutrient-rich 252 
conditions to suppress autophagy.  253 
 254 
Phosphorylation regulates the Beclin 1 interactome 255 
Several phosphorylation events can directly affect protein interactions, and shift the 256 
Beclin 1 interactome to induce or inhibit autophagy. In growth-factor rich conditions, 257 
active epidermal growth factor receptor (EGFR) binds Beclin 1, leading to multisite 258 
phosphorylation on residues Tyr229, Tyr233, and Tyr352, which decreases the Beclin 259 
1 interaction with VPS34 and increases its interaction with negative regulators such as 260 
RUBICON and BCL261. Inhibitory phosphorylation of Beclin 1 Tyr233 occurs also 261 
during phenylephrine-stimulated repression of autophagy, where focal adhesion 262 
kinase (FAK) seems to be the responsible modifier62. Another growth factor receptor 263 
that regulates autophagy by tyrosine phosphorylation on Beclin 1 was identified in 264 
human breast cancer cells63. Here, the activated human epidermal growth factor 265 
receptor 2 (HER2) was shown to bind Beclin 1 and phosphorylate Tyr233, a 266 
modification that leads to a decrease in both basal and starvation-induced autophagy63. 267 
However, the direct phosphorylation of these sites has not been verified in vitro, and 268 
therefore the possible involvement of other kinases and regulators cannot be excluded.  269 
 270 
As mentioned previously, the anti-apoptotic protein BCL2 affects the interaction 271 
between Beclin 1 and VPS34, and also sterically hinders accessibility for activating 272 
kinases54, 58. The interaction between Beclin 1 and BCL2 is itself highly regulated by 273 
phosphorylation, and can be prevented via direct phosphorylation of the BH3 domain 274 
in either Beclin1 or BCL2 to induce autophagy. Beclin 1 can be phosphorylated at 275 
Thr119 by DAPK or Rho kinase 1 (ROCK1)64, 65. ROCK1 may also prevent the 276 
inhibitory Beclin 1/BCL2 dimer formation upon nutrient stress by activating the c-Jun 277 
aminoterminal kinase 1 (JNK1) pathway, where JNK1 phosphorylates BCL265, 66. 278 
However, it is not clear which kinase is directly phosphorylating Thr119 of Beclin 1. 279 
There may be differences in this process between cell types and conditions, and it 280 
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should be noted that Thr119 phosphorylation was not observed upon starvation in an 281 
MCF7 cell line57. The phosphorylation that inhibits the Beclin 1-BCL2 interaction does 282 
not seem to interfere with Beclin 1 binding to AMBRA1, even though this positive 283 
autophagy regulator also binds Beclin 1 via the BH3 domain. This might be due to 284 
slightly different binding motifs, and it is possible that AMBRA1 interacts with Beclin 1 285 
also via other domains 46. 286 
 287 
Phosphorylation can also stabilize the interaction of Beclin 1 and BCL2 to inhibit 288 
autophagy, and possibly initiate apoptosis by limiting the amount of free BCL2 that can 289 
interact with and inactivate the pro-apoptotic protein BAX67. This is the case in 290 
cardiomyocytes, where stress-induced mammalian sterile 20-like kinase 1 (MST1) 291 
phosphorylates Beclin 1 in its BH3 domain at Thr108, promoting binding of Beclin 1 to 292 
BCL268. 293 
Activational ubiquitination of Beclin 1 294 
Ubiquitination of protein is a key regulatory step targeting proteins for degradation, but 295 
also could alter its localisation or composition and activity of multiprotein complexes.69. 296 
In the process of ubiquitination, ubiquitin is covalently attached to a lysine residue of a 297 
target protein by a cascade of enzymatic reactions involving E1, E2 and E3 enzymes. 298 
The action of ubiquitin ligases can be reversed by deubiquitinating enzymes (DUBs), 299 
a family of proteases that remove ubiquitin chains from substrate proteins by peptide 300 
cleavage.  301 
Beclin 1 is regulated by ubiquitination in numerous ways that affect its stability and 302 
function in the autophagy initiation process. The E3 ubiquitin ligase NEDD4 (neural-303 
precursor-cell-expressed developmentally down-regulated 4) was reported to interact 304 
with Beclin 1 via a PY-motif located downstream of the BARA domain (aa 349–352), 305 
to mediate Beclin 1 ubiquitination and degradation (Figure 3, Table 1)70. Levels of 306 
Beclin 1 correlate inversely with the levels of NEDD4, and enhanced expression of 307 
NEDD4 results in increased Lys11- and Lys63-linked polyubiquitination of Beclin 1 308 
both in vivo and in vitro, further establishing the role of NEDD4 in Beclin 1 regulation. 309 
While the role of NEDD4-mediated Beclin 1 ubiquitination in autophagy was not 310 
established in the initial studies, it was assumed that it would inhibit autophagy by 311 
promoting Beclin 1 degradation70. Controversially, other studies found the opposite to 312 
be true, claiming that NEDD4 is a positive regulator of autophagy71, 72. The 313 
contradictory results suggest that NEDD4 mediates mainly Lys6- and Lys27-linked 314 
ubiquitination of Beclin 1, which functions to protect Beclin 1 against Lys48-linked 315 
ubiquitination and stabilise protein levels during autophagy induction71. This study 316 
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further showed that NEDD4 also interacts with proteins of the ATG8 family and ULK1, 317 
extending the role of NEDD4 in autophagy regulation beyond its modification of Beclin 318 
1. 319 
 320 
Lys63-linked polyubiquitination of Beclin 1 has been linked to increased activity of the 321 
PI3K complex, and is considered to be a modification that positively regulates 322 
autophagy. During the inflammatory response in murine macrophage cells stimulated 323 
with the TLR4 agonist lipopolysaccharide (LPS) and interferon-γ, the E3 ligase TRAF6 324 
modifies Beclin 1 with Lys63-linked ubiquitin chains59. This posttranslational 325 
modification occurs on Beclin 1 Lys117, which is strategically located in the BH3 326 
domain of Beclin 1 (Figure 3A), and the modification was opposed by the activity of the 327 
deubiquitinating enzyme A20. Both TRAF6 and A20 were shown to bind Beclin 1 and 328 
the binding of TRAF6 was mapped to two sites, one in the Beclin 1 N-terminal domain 329 
(aa 54-58) and one in the C-terminal BARA domain (aa 297-301). The TRAF6-330 
mediated polyubiquitination of Beclin 1 affected oligomerisation of Beclin 1, inhibiting 331 
homodimerization and promoting complex formation with VPS34, thereby leading to 332 
autophagy induction59, 73. Additionally, Lys63-linked ubiquitination of Beclin 1 was 333 
enhanced by coexpression of the E3 ligase TRIM16, suggesting that this protein might 334 
be an additional regulator of Beclin 1 stability74. However, a direct interaction was not 335 
shown, and it is possible that this effect is mediated indirectly via other E3 ligases. 336 
 337 
During mouse embryonic development, Lys63-linked ubiquitination of Beclin 1 is 338 
necessary to maintain autophagic flux and ensure embryonic survival75. In this 339 
scenario, Lys437 is the main target residue and ubiquitination is suggested to be 340 
mediated by the DDB1–Cullin 4 E3 ubiquitin ligase complex containing AMBRA1 as 341 
the substrate receptor to mediate the interaction with Beclin 1 (Figure 3A, 3C, Table 342 
1)75, 76. The WASH (Wiskott–Aldrich syndrome protein (WASP) and SCAR Homologue) 343 
protein was identified as a negative regulator of autophagy by binding Beclin 1 and 344 
inhibiting Beclin 1 Lys63-linked ubiquitination to suppress PI3K activity. WASH was 345 
shown to bind  the central region of Beclin 1, competing with AMBRA1, and this 346 
interaction was decreased upon starvation-induced autophagy. Consistently, WASH 347 
deficiency increased Beclin 1 Lys63-linked ubiquitination and enhanced autophagy 348 
induction in mouse embryos75. 349 
 350 
A more recent study identified Tripartite motif protein 50 (TRIM50) as another E3 ligase 351 
responsible for Beclin 1 Lys63-linked ubiquitination, showing that TRIM50 dependent 352 
ubiquitination of Beclin 1 increases during autophagy-inducing conditions, such as 353 
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starvation or treatment with rapamycin77. The ubiquitination of Beclin 1 did not affect 354 
interactions with VPS34, but did increase the interactions between the PI3K complex 355 
and ULK1, which could account for the activation of autophagy. In addition, TRIM50 356 
activity was dependent on acetylation by the acetyltransferase EP300, placing Beclin 357 
1 activating ubiquitination downstream of regulation governed by acetylation77.  358 
 359 
The activating effect of Beclin 1 Lys63-linked ubiquitination is counteracted by the 360 
deubiquitinating enzyme USP1478. USP14 interacts directly with the Beclin 1 CCD, and 361 
depletion of USP14 or treatment with its inhibitor increases Beclin 1 Lys63-linked 362 
ubiquitination and promotes the Beclin 1 interaction with ATG14L and UVRAG, but not 363 
with VPS34. Thus, absence of USP14 increases activation of the VPS34 complex 364 
without changing the levels of the key PI3K complex components, and promotes both 365 
autophagy initiation and autophagosome maturation by enhancing the activity of PI3K 366 
complexes I and II. Moreover, USP14 deubiquitinating activity is suggested to be 367 
regulated by AKT-mediated phosphorylation, providing evidence for the upstream 368 
signalling events governing Beclin 1 ubiquitination78.  369 
 370 
Ubiquitination and deubiquitination regulate Beclin 1 levels 371 
Beclin 1 is marked for degradation via modification by Lys48-linked ubiquitin. Thus, 372 
any proteins that increase this modification would be predicted to be negative 373 
regulators of autophagy. In macrophages, the E3 ligase RNF216 (ring finger protein 374 
216) was identified as the protein responsible for Beclin 1 degradation79, and 375 
overexpression of RNF216 was shown inhibit TLR-mediated autophagy induction in 376 
bacteria-infected mice, indicating that it is an important regulator of autophagy in the 377 
pathogen response79. 378 
 379 
The CUL3-KLHL20 ubiquitin ligase complex is another E3 ligase that governs 380 
autophagy by facilitating degradation of several autophagy proteins during prolonged 381 
starvation-induced autophagy80. KLHL20 was shown to directly bind and ubiquitinate 382 
ULK1, VPS34 and Beclin 1 at the phagophore to promote their degradation and 383 
prevent unrestrained autophagic activity during prolonged starvation80. Consequently, 384 
KLHL20 depletion caused an increase in the amplitude and duration of starvation-385 
induced autophagy and reduced cell survival.  386 
 387 
Deubiquitinating enzymes (DUBs) that remove Lys48-linked ubiquitin chains 388 
counteract the degradation signal from E3 ligases and rescue proteins from 389 
degradation. USP10 and USP13 were identified as two deubiquitinases that target and 390 
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stabilise Beclin 181. Depletion of USP10 and USP13 reduced levels of VPS34, Beclin 391 
1, ATG14L, VPS15 and UVRAG, replicating the effects observed when treating cells 392 
with Spautin-1, a compound known to inhibit the two deubiquitinating enzymes. 393 
Intriguingly, the interaction between Beclin 1 and USP10/USP13 does not only 394 
stabilise Beclin 1 levels, but also reciprocally stabilises the deubiquitinases. Thus, 395 
Beclin 1 could be considered a regulator of other USP10 and USP13 targets, one of 396 
which is the tumour suppressor protein p5382. All together, these results provide one 397 
mechanism to explain the tumour suppressor function of Beclin 1, and illustrate that 398 
PI3K components can regulate their own levels via feedback control of USP10 and 399 
USP1381. Another mechanism that may contribute to the tumour suppressor properties 400 
of Beclin 1, in addition to its role in autophagy, is mediated by the USP9X 401 
deubiquitinase, which is another modifier of Beclin 183. Beclin 1 competes with the 402 
antiapoptotic protein MCL1 for binding to USP9X and thus the levels of Beclin 1 and 403 
MCL1 are reciprocally regulated, providing cells with a way of upregulating autophagy 404 
at the same time as inducing apoptosis to prevent unrestriced cell growth83. 405 
 406 
Most recently, the deubiquitinase ATAXIN3 was also reported to control Beclin 1 407 
stability upon starvation induced autophagy31. Depletion of ATAXIN3 caused a 408 
decrease in autophagy flux as well as a decrease in the Beclin 1 levels. The drop in 409 
Beclin 1 levels was correlated with an increase in Lys48-linked ubiquitination and the 410 
Lys402 site within Beclin 1 BARA domain was shown to be a major site for ATAXIN3-411 
mediated deubiquitination (Figure 3, Table 1). Furthermore, these proteins were shown 412 
to directly interact through Beclin 1 BARA domain and ATAXIN3 polyQ region. 413 
Interestingly, this interaction was compromised in the presence of neurodegenerative 414 
disease-causing polyQ-expanded proteins, like mutant huntingtin, resulting in the 415 
decrease in Beclin 1 levels and impaired starvation-induced autophagy31.  416 
 417 
Proteolytic cleavage of Beclin 1 418 
Specific proteolytic events often regulate protein activity and function. Beclin 1 can be 419 
regulated by a direct cleavage of its polypeptide chain into fragments, thereby 420 
providing additional means for regulating the autophagic response. Beclin 1 cleavage 421 
by caspases has been demonstrated, and provides a direct link between autophagy 422 
and apoptosis84, 85, 86. Upon prolonged withdrawal of growth factors, treatment with pro-423 
apoptotic compounds or overexpression of pro-apoptotic BAX, Beclin 1 was cleaved 424 
into three major fragments of 50, 37 and 35 kDa85, 86. Beclin 1 was specificly cleaved 425 
in the presence of Caspase 3, 7 and 8 and the generated fragments resulted from 426 
Caspase-3-mediated cleavage after TDVD133 and DQLD149 sites (Figure 3, Table 1). 427 
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Generated N-terminal fragments of Beclin 1 relocalise to the nucleus or mitochondria, 428 
enhancing cellular apoptotic response85, 86, 87. The caspase-3 mediated Beclin 1 429 
cleavage can be inhibited by treatment with spermidine, revealing a neuroprotective 430 
effect through restoration of Beclin 1-dependent autophagy88. Additionally, Beclin 1 431 
was shown to be a substrate for calpain-mediated cleavage following retinal ischemic 432 
injury in rats, although the exact cleavage site was not identified89. 433 
 434 
 435 
Other post-translational modifications of Beclin 1 436 
Acetylation is an additional important post-translational modification of proteins, and 437 
proteomic studies have identified thousands of acetylated proteins in mammalian cells, 438 
including Beclin 1, where this modification appears to be an important regulatory 439 
mechanism governing Beclin 1 function in autophagosome maturation90. Beclin 1 was 440 
found to be acetylated at Lys430 and 437 by EP300 and this modification was further 441 
shown to promote the binding of Beclin 1 to RUBICON, providing a mechanism for 442 
negative regulation of autophagy90. Beclin 1 interaction with EP300 and subsequent 443 
acetylation is enhanced when Beclin 1 is phosphorylated at Ser409 by CK1γ2 (Casein 444 
kinase 1 gamma 2). Finally, Beclin 1 acetylation and its increased interaction with 445 
RUBICON was shown to inhibit intracellular trafficking of autophagosomes and 446 
endocytic cargo to lysosomes for degradation90.  447 
 448 
The ubiquitin-like type modifier, ISG15, is one of the major interferon I stimulated gene 449 
products (ISGs) and can be conjugated to the target protein (ISGylation) as part of the 450 
antiviral immune response. The ISG-conjugating enzyme, HERC5, and ISG-451 
deconjugating enzyme, USP18, were shown to interact directly with the BH3 domain 452 
and CCD of Beclin 1 in cells stimulated with type I interferon91. The ISGylation of Beclin 453 
1 was shown to decrease the activity of the PI3K complex by competing with Beclin 1 454 
Lys63 ubiquitination which is essential for Beclin 1 activation, thereby decreasing 455 
autophagy response91. However, these findings have not been validated in other 456 
systems, and might correspond to a cell type-specific response. 457 
 458 
The O-Linked β-N-acetylglucosamine (O-GlcNAc) modification is a dynamic, distinct 459 
form of protein glycosylation that can occur within the nucleus, cytoplasm or 460 
mitochondria as a response to cellular stress. Beclin 1 and BCL2 appear to be targets 461 
of O-GlcNAc modification in cardiomyocytes isolated from diabetic mice, however the 462 
impact of this modification on autophagy process remains elusive92. 463 
 464 
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 465 
Future perspectives 466 
Post-translational modification of proteins has been revealed as an essential 467 
regulatory mechanism for controlling autophagy. By regulating the assembly and 468 
activity of the PI3K complex and recruitment of critical autophagy effectors, Beclin 1 469 
has emerged as a critical regulatory node and a possible point for intervention to 470 
modify autophagic flux. Pharmacological stimulation of autophagy appears to be 471 
desirable, as an increase in autophagy flux has been shown to reduce levels of harmful 472 
aggregated protein species involved in neurodegeneration93, 94, 95, 96, and targeting 473 
Beclin 1 modifications could constitute a way of achieving this. The feasibility of this 474 
approach was indicated by mouse model studies where the inhibitory interaction of 475 
Beclin 1 and BCL2 was obstructed, and these mice showed signs of increased 476 
autophagic flux, increased neuroprotection and extended lifespan45, 97. While this study 477 
was based on a genetic disruption of the Beclin1-BCL2 complex, other studies are 478 
investigating the viability of BH3 mimetics for this approach98, 99. Additional studies 479 
have developed small peptides to alter Beclin 1 interactions, and these have been 480 
proved to be sufficient to regulate autophagy in in vivo settings relevant for disease63, 481 
100, 101, 102, 103. 482 
 483 
As phosphorylation of Beclin 1 Ser90 seems to be a key event for autophagy activation 484 
in many tissues, blocking or inhibiting this modification might provide a conceivable 485 
approach for developing an autophagy-modulating drug. Another approach to modify 486 
Beclin 1-dependent autophagy could be to alter levels of Beclin 1 by targeting E3 487 
ligases or deubiquitinating enzymes104, 105. The example of using the DUB inhibitor 488 
Spautin-1 have already been mentioned and, as another example, small molecule 489 
inhibitors targeting USP14 have been developed and are showing promising results in 490 
neuroprotection81, 106. However, specific targeting of modifying enzymes can be 491 
challenging as enzymes of a particular family often share similar domains and structure. 492 
Furthermore, as many enzymes have a wide range of substrates, inhibition may impact 493 
other cellular pathways. An alternative approach could be to specifically inhibit certain 494 
modifications by developing peptides or small-molecules that target a specific site on 495 
the substrate, similar to what was recently reported for blocking the phosphorylation of 496 
the apoptotic protein BAD107. 497 
 498 
Future studies of Beclin 1 function are needed to uncover additional layers of regulation 499 
by post-translational modifications. There are several post-translational modifications 500 
such as methylation, SUMOylation, and oxidation that have been identified as 501 
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regulators of other key autophagy proteins108, 109, 110, 111, and prediction tools reveal that 502 
Beclin 1 might be a target for several of these modifications112. However, it remains to 503 
be determined whether any of these predicted sites are utilised in vivo. Another future 504 
direction in the research on post-translational regulation of autophagy would be to 505 
identify the proteins that are responsible for reversing the modifications, such as 506 
phosphatases, deubiquitinating enzymes and deacetylases. It also remains to be 507 
determined how different modifications might be affecting each other, and how 508 
regulation might diverge in different tissues and conditions.  509 
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Table 1: Post-translational modifications of Beclin 1.  524 
Known residues of Beclin 1 targeted for modification, the modifying enzyme and the 525 
relevance of that modification in terms of autophagy (activation/inhibition). The table 526 
also lists the autophagy-inducing conditions used and what systems/ cell models were 527 
used to establish the modification of Beclin 1, and whether the modification was 528 
confirmed in vitro. 529 
  530 
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Site Modification Modifier Consequence Conditions, cell system Reference 
Ser15 Phosphorylation ULK1 Activation Amino acid starvation, MEFs, HEK293, C 
elegans, in vitro.  
18 
Ser90 
Ser93 
Phosphorylation AMPK Activation Glucose starvation, HeLa, MEFs, in vitro 53 
36 
 
Thr388 Phosphorylation AMPK Activation Glucose starvation, HEK293T, MEFs, 
treatment with AMPK stimulator/inhibitor, 
in vitro 
55 
Ser90 Phosphorylation MAPKAPK2/3 Activation starvation (HBSS), HeLa, MEFs,  
in vitro 
54 
Ser90 Phosphorylation DAPK3 Activation Serum starvation, mouse tissues, HeLa, 
MCF7, in vitro 
57 
Ser90 Dephosphorylation PP2A Inhibition Insulin addition, okadic acid treatment, 
mouse tissues, HeLa, MCF7, in vitro 
57 
 
Ser90 Phosphorylation CaMKII Activation Ionomycin treatment, HEK293,  
in vitro 
58 
Ser30 Phosphorylation PGK1 Activation Glutamine starvation, Hypoxia, U87, 
BxPC-3, MDA-MB-231,    
in vitro 
60 
Ser234 
Ser295 
Phosphorylation AKT1 Inhibition Starvation (EBSS), HeLa, 
in vitro 
26 
Tyr229 
Tyr233 
Tyr352 
Phosphorylation EGFR Inhibition Serum starvation, HeLa, A549 61 
Tyr233 Phosphorylation FAK Inhibition Phenylephrine treatment, Cardiomyocytes, 
Cos 
62 
Tyr233 Phosphorylation HER2 Inhibition Basal conditions, serum starvation, HER2-
positive breast cancer cell lines (BT-474, 
SK-BR3, and MDA-MB-361) 
63 
Thr119 Phosphorylation DAPK Activation Basal condition, HEK293,  
in vitro 
64 
Thr119 Phosphorylation ROCK1 Activation starvation (HBSS), HeLa, MEFs, in vitro 65 
Thr108 Phosphorylation MST1 Inhibition Glucose starvation, cardiomyocytes, in 
vitro 
68 
- Lys11- and Lys63- 
linked ubiquitination 
NEDD4 Inhibition? Basal conditions, HeLa. Role in autophagy 
not established. 
70 
- Lys6- and Lys27- 
linked ubiquitination 
NEDD4 Activation Basal conditions, Torin treatment, HeLa, 
HEK293, MEFs 
71 
Lys117 Lys63- linked 
ubiquitination 
TRAF6 Activation LPS and IFN-γ treatment, starvation 
(HBSS), mouse macrophages (RW264.7), 
primary human monocytes 
59 
Lys437 Lys63- linked 
ubiquitination 
AMBRA1 Activation Starvation (HBSS), MEFs, HeLa 75 
- Lys63- linked 
ubiquitination 
TRIM50 Activation Basal condition, starvation (EBSS), 
rapamycin treatment, HEK293, HeLa, 
MEFs 
77 
- Lys63-deubiquitination USP14 Inhibition Serum starvation, H4 78 
- Lys48-linked 
ubiquitination 
RNF216 Inhibition LPS treatment, starvation (HBSS), mouse 
macrophages (RW264.7),HEK293T 
79 
 17 
 531 
  532 
- Lys48-linked 
ubiquitination 
KLHL20 Inhibition Starvation (HBSS), HeLa, mouse muscle 
cells, HEK293T 
80 
- Lys48-deubiquitination USP10, USP13 Activation Basal conditions, MEFs, HeLa, HEK293T, 
H4, Bcap-37 
81 
- deubiquitination USP9X Activation Basal conditions, HEK293T 83 
Lys402 Lys48-deubiquitination ATAXIN3 Activation Starvation (HBSS), HeLa, primary 
neurons, mouse striatal-derived cells 
31 
      
- cleavage CASP3,6,9,10  Basal conditions, HeLa 84 
TDVD133 
DQLD149 
cleavage CASP3,7 and 8 Inhibition Growth-factor withdrawal (interleukin-3), 
pro-apoptotic compounds, mouse  (Ba/F3, 
FDCP1) and human (U937) cell lines, 
HeLa 
86 
DQLD149 cleavage CASP3 Inhibition BAX overexpression, pro-apoptotic 
compounds, HeLa, SK-N-SH, MEFs 
85 
- cleavage Calpain Inhibition Ischemia injury, Rat retina 89 
Lys430 
Lys437 
acetylation EP300 Inhibition Basal conditions, HEK293T, MCF7, HeLa,  90 
Ser409 Phosphorylation CK1γ2 Inhibition Serum starvation, HEK293 90 
Lys430 
Lys437 
deacetylation SIRT1 Activation Basal conditions, HEK293T, MCF7 90 
Lys117 
Lys263 
ISGylation HERC5/USP18 Inhibition Type I interferons treatment, H4 cells, 
HepG2, HEK293T,  
91 
- O-GlcNAc - - Cardiomyocytes 92 
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Figure legends 533 
 534 
Figure 1: Autophagy initiation depends on ULK1 priming and PI(3)P production. 535 
Upon autophagy initiation signals, the ULK1 complex (containing ULK1 or ULK2) 536 
activates the PI3K complex, which directs PI(3)P production to a membrane site. The 537 
PI(3)P-rich membrane recruits downstream autophagy effectors, like WIPI proteins 538 
and ATG16L, which mediates the membrane conjugation of LC3. LC3 then stimulates 539 
membrane expansion and cargo recruitment into the forming phagophore. 540 
 541 
Figure 2: Upstream modulation of autophagy responds to nutritional cues and 542 
converges on regulation of the Beclin 1-containing PI3K complex 543 
When amino acids are abundant, mTORC1 is active and phosphorylates and inhibits 544 
the autophagy-priming complex ULK1. This prevents ULK1 from activating the PI3K 545 
complex to initiate PI(3)P production. During amino acid starvation, the inhibitory effect 546 
of mTORC1 is released and autophagy can be induced. The presence of growth 547 
factors is sensed by the AKT kinase, which activates mTORC1 and inhibits PI3K 548 
activity. Cellular energy status can also be detected via the AMP/ATP ratio, where 549 
increase in AMP activates the kinase AMPK, which activates autophagy via mTORC1 550 
inhibition, ULK1 activation, and PI3K activation. 551 
 552 
Figure 3: Positions of Beclin 1 post-translational modifications 553 
 A-B) Linear domain structure of Beclin 1 indicating the BCL2 homology 3 domain 554 
(BH3), Helical domain (HD), coiled-coiled domain (CCD), and ß/α-repeated, autophagy 555 
related (BARA) domain. Known post-translational modifications are indicated by 556 
position and type: P = phosphorylation, Ub = ubiquitination, Ac = Acetylation ISG = 557 
ISGylation. Modifications known to induce autophagy are illustrated in A) and 558 
modifications known to inhibit autophagy are shown in B). Further details on 559 
modifications can be found in table 1. 560 
C) Positions of post-translational modifications of Beclin 1. Beclin 1 is visualized 561 
oriented in the PI3K complex II (in light grey) in a structure model based on the crystal 562 
structure of the yeast PI3K complex, with the Beclin 1 homologue Atg6113. Domains 563 
important for Beclin 1 interactors are denoted in dashed lines with labels for interactors. 564 
The orientation of Beclin 1 in the complex is indicated by denotation of the C- and N-565 
terminals. The N-terminal of Beclin 1 is intrinsically disordered and has no determined 566 
crystal structure; therefore this part is represented only by a gray surface 567 
representation without the overlay of a ribbon model. Protein structure downloaded 568 
from iCn3D web viewer114  569 
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